This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Mar;27(3):545-6.

doi: 10.1093/annonc/mdv600. Epub 2015 Dec 12.

Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy

I F Tannock¹, C N Sternberg²

Affiliations

Affiliations

¹ Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada ian.tannock@uhn.ca.
² Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy.

PMID: 26659397
DOI: 10.1093/annonc/mdv600

Free article

Comment

Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy

I F Tannock et al. Ann Oncol. 2016 Mar.

Free article

. 2016 Mar;27(3):545-6.

doi: 10.1093/annonc/mdv600. Epub 2015 Dec 12.

Authors

I F Tannock¹, C N Sternberg²

Affiliations

¹ Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada ian.tannock@uhn.ca.
² Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy.

PMID: 26659397
DOI: 10.1093/annonc/mdv600

No abstract available

PubMed Disclaimer

Comment in

Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al.
Parker C, Gillessen S, Heidenreich A, Horwich A. Parker C, et al. Ann Oncol. 2016 Apr;27(4):750-1. doi: 10.1093/annonc/mdw023. Epub 2016 Jan 22. Ann Oncol. 2016. PMID: 26802159 No abstract available.

Comment on

Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Parker C, Gillessen S, Heidenreich A, Horwich A; ESMO Guidelines Committee. Parker C, et al. Ann Oncol. 2015 Sep;26 Suppl 5:v69-77. doi: 10.1093/annonc/mdv222. Epub 2015 Jul 22. Ann Oncol. 2015. PMID: 26205393 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information